Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

80 results about "Tracheal stent" patented technology

Laryngeal and tracheal stents are solid or hollow absorbable or nonabsorbable tubes of various shapes, sizes, and materials. Stents are used as primary treatment for lumen collapse or to stabilize a reconstructive effort of the larynx or trachea to prevent collapse.

Medicine-carrying nanofiber membrane biliary stent and preparation method thereof

The invention discloses a medicine-carrying nanofiber membrane biliary stent and a preparation method thereof. The medicine-carrying nanofiber membrane biliary stent comprises one part of nanofiber inner layers, the other part of nanofiber inner layers, a metal support and a medicine-carrying degraded fiber outer layer from inside to outside, wherein one part of nanofiber inner layers are arrayed in the pipe diameter direction, and the other part of nanofiber inner layers are arrayed disorderly. The nanofiber inner layers arrayed in the pipe diameter direction and the nanofiber inner layers arrayed disorderly are bonded together. The nanofiber inner layers arrayed disorderly and the medicine-carrying degraded fiber outer layer are boned together through meshes of the metal support, and the metal support is firmly fixed in a fiber membrane. The preparation method includes that electrostatic spinning equipment is adopted for electrostatic spinning. Compared with a micro-nano ball, the nanofiber membrane biliary stent has better structural stability, can be used for treating biliary stricture caused by tumors, has a mechanical expansion effect and a local treatment function, and can solve the biliary malignant stricture better than a common stent or a membrane-covering stent. In addition, the method can be applied to gastrointestinal tract stents and tracheal stents.
Owner:张建平

Preparation method and application of a biological composite artificial trachea

The present invention provides a biological composite artificial trachea and its preparation method in combination with 3D printing technology. The material used in the present invention has both flexibility and certain mechanical strength, which meets the physical and mechanical properties of the trachea as a hollow organ in the thoracic cavity; secondly, The artificial trachea of ​​the present invention has a porous and loose structure, which is conducive to the diffusion of nutrients and the growth of autologous blood vessels; in addition, the present invention prints the seed cells obtained from the expansion of the recipient's own airway epithelial cells and chondrocytes in the trachea wall, The patient's rejection of the cells is avoided; moreover, the seed cells are composed of terminally differentiated mature cells, which avoids the problem of inducing differentiation and the risk of tumor formation caused by the use of stem cells; at the same time, the spatial distribution of the cells in the present invention is The printing is precise and controllable, and the distribution according to histological laws accelerates the repair process; finally, the tracheal stent can be degraded in the body, reducing the complications caused by foreign body residues in the body, and avoiding the risk of secondary surgical removal.
Owner:SHANGHAI PULMONARY HOSPITAL +1

3D printed embeddable double-layer PCL (polycaprolactone) slow-degradation tissue engineering tracheal stent with incomplete tracheal ring and application of stent

PendingCN107981954AHas growth potentialMaintain expectoration abilityAdditive manufacturing apparatusTracheae3d printInsertion stent
The invention relates to a PCL (polycaprolactone) slow-degradation tracheal stent. The stent comprises an outer stent and an inner stent, wherein the outer stent is a hollow C-shaped circular tube, the inner stent is a hollow circular tube, a hollow C-shaped ring is arranged on the outer surface of the outer stent, and the inner stent is embedded in the outer stent. The invention further providesa slow-degradation tissue engineering trachea and an application thereof. The tracheal stent has the advantages as follows: the tracheal stent is completely bionic in terms of organizational structure, the outer layer is tracheal cartilage, and the inner layer is ciliated columnar epithelium, tracheal toughness is achieved, expectoration capacity is maintained, and the incidence of infection aftertransplantation can be reduced; moreover, the tracheal ring is incomplete, has growth potential and can be applied to minor organisms. The tracheal stent can be made into any diameter, and can meet individualized requirements. The PCL stent can be degraded in vivo completely and slowly and is non-toxic to bodies.
Owner:SHANGHAI CHILDRENS MEDICAL CENT AFFILIATED TO SHANGHAI JIAOTONG UNIV SCHOOL OF MEDICINE

Manufacturing method of controllable antibacterial tracheal stent

The invention discloses a manufacturing method of a controllable antibacterial tracheal stent. The manufacturing method comprises the following steps of S1, preparing an antibacterial solution and a biocompatible degradable substrate material; S2, according to requirements, determining the geometric parameters and antibacterial component concentration of a degradable antibacterial layer at the surface of a substrate of the tracheal stent; S3, according to the geometric parameters and antibacterial component concentration in S2, calculating the printing route and printing parameters; S4, according to the printing route and printing parameters in S3, printing a degradable antibacterial mixing material at the surface of the substrate of the tracheal stent; S5, curing the printed degradable antibacterial mixing material, and curing the degradable antibacterial layer into a film. After the tracheal stent manufactured by the method is implanted into a human body, the antibacterial componentsare released along with the gradual degrading of the degradable substrate material; the release rate, concentration, antibacterial time and the like of the antibacterial components are controlled bycontrolling the antibacterial component concentration and the geometric parameters of the antibacterial layer, so that the implanted tracheal stent can reach the controllable antibacterial effect.
Owner:ZHEJIANG UNIV

3D printing incomplete tracheal ring embeddable double-layered PLLA tissue engineering tracheal stent and its application

PendingCN107854195AHas growth potentialMaintain expectoration abilityTracheae3d printTracheal tube
The invention relates to a 3D printed incomplete tracheal ring that can be embedded in a double-layer PLLA tissue engineering tracheal stent and its application, including a PLLA degradable tracheal stent with an incomplete tracheal ring on the outer layer and an incomplete inner layer The PLLA degradable tracheal stent with tracheal ring; the PLLA degradable tracheal stent with an incomplete tracheal ring on the outer layer is composed of an outer PLLA degradable tracheal stent and an incomplete tracheal ring; the side design of the outer PLLA degradable tracheal stent There is a stent gap through the tube wall and several incomplete tracheal rings; there is a through tracheal ring gap on the incomplete tracheal ring; the inner layer does not have a PLLA degradable tracheal stent nested with incomplete tracheal rings Inside the tube of a PLLA degradable tracheal stent with an incomplete tracheal ring on the outer layer. Its advantages are: completely bionic, which not only has the toughness of the trachea but also maintains the ability to expel sputum, reduces the incidence of infection after transplantation, and can be applied to minors; the tracheal stent can be degraded in the body and is non-toxic to the body.
Owner:SHANGHAI CHILDRENS MEDICAL CENT AFFILIATED TO SHANGHAI JIAOTONG UNIV SCHOOL OF MEDICINE

Bionic composite artificial trachea and preparation method thereof

PendingCN111643220AReduce the chance of infection and ruptureImprove adhesionTracheaeTissue regenerationSurgical operationTracheal surgery
The invention provides a bionic composite artificial trachea. The bionic composite artificial trachea comprises an artificial trachea wall, a trachea stent arranged on the outer side of the artificialtrachea wall and a gasket wrapping the edge of the trachea stent, wherein the artificial trachea wall comprises a biological patch layer and an absorbable biological material layer from inside to outside. According to the bionic composite artificial trachea, the biological patch layer and the absorbable biological material layer serve as the artificial trachea wall, and the trachea stent is arranged, so that ventilation is good, the bionic composite artificial trachea can deform slightly along with airway pressure and has certain telescopic elasticity, the head of a patient can move freely, and the trouble that the neck needs to be fixed after a traditional trachea operation is avoided; meanwhile, the gasket can prevent the tail end of the trachea stent from contusion of surrounding organs due to friction at the initial stage of implantation; in conclusion, the bionic composite artificial trachea provided by the invention can realize clinical application, and can solve the problem that no effective trachea substitute is available for first-stage trachea reconstruction when an ultra-long trachea is excised in a tracheal surgical operation at present in one operation.
Owner:THE SECOND XIANGYA HOSPITAL OF CENT SOUTH UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products